News

The European Medicines Agency's safety committee said on Friday Novo Nordisk's popular weight-loss and diabetes drugs Wegovy ...
The European Medicines Agency's safety committee has concluded that the use of Novo Nordisk's popular weight-loss drug Wegovy ...
Patients taking weight-loss medicines such as Novo Nordisk A/S’s Ozempic and Wegovy are at risk of developing an eye ...
The European Medicines Agency’s (EMA) safety committee, PRAC, said Friday that it has concluded that Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), a rare eye condition that can lead to ...
Novo Nordisk's (NVO) weight loss drug semaglutide (Ozempic, Wegovy, Rybelsus) is linked to a rare eye condition called NAION ...
A 48-year-old from Suffolk County is one of over 30 people suing Ozempic's manufacturer for partial loss of vision.
While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...
Semaglutide effects the salivary glands in the mouth. It does this by reducing saliva production ( hyposalivation ), which ...
Dozens of Ozempic and Wegovy users have reported suffering from eye disorders they claim are associated with the drugs, ...